Josselin Caradec

Josselin Caradec is an experienced biotechnology professional currently serving as the Head of Biology at ThirtyFiveBio and a Consultant Expert at Bpifrance since November 2022. As a co-founder and CEO of the Drug Discovery Centre, Josselin focuses on advancing early therapeutic projects through strategic consulting and operational drug discovery platforms. Previous roles include Director of Operations at Tyris Therapeutics, where innovative gene therapies were developed, and Program Director at Oncodesign, overseeing drug discovery programs in oncology and immunology. With a strong foundation in research, Josselin contributed to significant projects as a Post-Doctoral Fellow at the Vancouver Prostate Centre and as a Research Scientist at BioQuanta. Josselin holds a PhD in Molecular and Cellular Biology from Paris EST and a Master's degree in Pharmacology and Cellular Biology from Paris V and Paris VII.